Thomas Gauler

12.5k citations

152 papers · 3.1k indexed · h-index 30

Impact in

Otorhinolaryngology top 0.5%
- Head and Neck Cancer Studies
Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies

Papers in

Otorhinolaryngology 36
- Head and Neck Cancer Studies 36
Pulmonary and Respiratory Medicine 104
- Lung Cancer Treatments and Mutations 66
- Lung Cancer Diagnosis and Treatment 33
- Renal cell carcinoma treatment 11

Co-authors: Wilfried Eberhardt Martin Stuschke Georgios Stamatis Ulrich Keilholz Christoph Pöttgen Martin Schüler Dirk Theegarten Lisa Licitra
Journals: Journal of Clinical Oncology (31 papers)Annals of Oncology (17 papers)European Journal of Cancer (8 papers)Journal of Thoracic Oncology (6 papers)International Journal of Radiation Oncology*Biology*Physics (4 papers)
Partner nations: Germany United States France

In The Last Decade

Thomas Gauler

147 papers receiving 3.1k citations

Peers

Countries citing papers authored by Thomas Gauler

Since Specialization

Citations

This map shows the geographic impact of Thomas Gauler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Gauler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Gauler more than expected).

Fields of papers citing papers by Thomas Gauler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Gauler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Gauler. The network helps show where Thomas Gauler may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas Gauler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas Gauler Line = papers co-authored together Thomas Gauler links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Long-Term Survival in Patients with Oligometastatic Non-Small Cell Lung Cancer by a Multimodality Treatment—Comparison with Stage III Disease Cancers ·Maja Guberina, Christoph Pöttgen, Nika Guberina, Christian Hoffmann, Marcel Wiesweg, Cedric Richlitzki, Martin Metzenmacher, Clemens Aigner, Servet Bölükbas, Thomas Gauler, Wilfried Eberhardt, Michael Forsting, Ken Herrmann, Dirk Theegarten, Kaid Darwiche, Verena Jendrossek, Martin Stuschke, Martin Schüler	2024	3
2	Respiration-controlled radiotherapy in lung cancer: Systematic evaluation of the optimal application practice Clinical and Translational Radiation Oncology ·Maja Guberina, Alina Santiago, Christoph Pöttgen, Frank Indenkämpen, Wolfgang Lübcke, Sima Qamhiyeh, Thomas Gauler, Christian Hoffmann, Nika Guberina, Martin Stuschke	2023	3
3	Fractionation versus Adaptation for Compensation of Target Volume Changes during Online Adaptive Radiotherapy for Bladder Cancer: Answers from a Prospective Registry Cancers ·Christoph Pöttgen, Christian Hoffmann, Thomas Gauler, Maja Guberina, Nika Guberina, Toke Printz Ringbæk, Alina Santiago Garcia, Ulrich Krafft, Boris Hadaschik, Aymane Khouya, Martin Stuschke	2023	5
4	Adaptation Time as a Determinant of the Dosimetric Effectiveness of Online Adaptive Radiotherapy for Bladder Cancer Cancers ·Aymane Khouya, Christoph Pöttgen, Christian Hoffmann, Toke Printz Ringbæk, Wolfgang Lübcke, Frank Indenkämpen, Maja Guberina, Nika Guberina, Thomas Gauler, Martin Stuschke, Alina Santiago Garcia	2023	3
5	MRI-based long-term follow-up of indolent orbital lymphomas after curative radiotherapy: imaging remission criteria and volumetric regression kinetics Scientific Reports ·Christian Hoffmann, Christopher Mohr, Patricia Johansson, Anja Eckstein, Andreas Huettmann, Julia von Tresckow, Sophia Göricke, Cornelius Deuschl, C. Poettgen, Thomas Gauler, Nika Guberina, Sourour Moliavi, Nikolaos E. Bechrakis, Martin Stuschke, Maja Guberina	2023	1
6	1988MO Recruitment discontinuation in TREASURE trial (thoracic radiotherapy with atezolizumab in small cell lung cancer extensive disease) due to unexpected safety data Annals of Oncology ·Farastuk Bozorgmehr, Fabian Weykamp, Tobias R. Overbeck, Nicola Maguire, E.L. Buchmeier, M. Hammer-Hellmig, Thomas Gauler, Martin Wermke, Esther G.C. Troost, Matthias Ulmer, A-C. Mueller, Konrad Kokowski, Barbara Röper, Thomas Wehler, S. Hey-Koch, N.-S Consdorf, Rouven Behnisch, Petros Christopoulos, Michael Thomas, Stefan Rieken	2023	7
7	Comparison of Online-Onboard Adaptive Intensity-Modulated Radiation Therapy or Volumetric-Modulated Arc Radiotherapy With Image-Guided Radiotherapy for Patients With Gynecologic Tumors in Dependence on Fractionation and the Planning Target Volume Margin JAMA Network Open ·Maja Guberina, Alina Santiago Garcia, Aymane Khouya, Christoph Pöttgen, Kostyantyn Holubyev, Toke Printz Ringbæk, Manfred Lachmuth, Yasemin Alberti, Christian Pieter Hoffmann, Julian Hlouschek, Thomas Gauler, Wolfgang Lübcke, Frank Indenkämpen, Martin Stuschke, Nika Guberina	2023	13
8	Long‐term follow‐up and health‐related quality of life among cancer survivors with stage IEA orbital‐type lymphoma after external photon‐beam radiotherapy: Results from a longitudinal study Hematological Oncology ·Christian Hoffmann, Philipp Rating, Nikolaos E. Bechrakis, Anja Eckstein, Ekaterina Sokolenko, Leyla Jabbarli, Henrike Westekemper, Christopher Mohr, Claus Schmeling, Andreas Huettmann, Julia von Tresckow, Sophia Göricke, Cornelius Deuschl, Patricia Johansson, Christoph Poettgen, Thomas Gauler, Nika Guberina, Sourour Moliavi, Martin Stuschke, Maja Guberina	2022	2
9	Patterns of cervical lymph node metastasis in supraglottic laryngeal cancer and therapeutic implications of surgical staging of the neck European Archives of Oto-Rhino-Laryngology ·Cornelius Kürten, Eleni Zioga, Thomas Gauler, Martin Stuschke, Maja Guberina, Johannes Ludwig, Eric Deuß, Stefan Mattheis, Stephan Lang, Timon Hussain	2021	13
10	Dosimetric impact of the positioning variation of tumor treating field electrodes in the PriCoTTF‐phase I/II trial Journal of Applied Clinical Medical Physics ·Younèss Nour, Christoph Pöttgen, Sied Kebir, Lazaros Lazaridis, Lutz Lüdemann, Maja Guberina, Thomas Gauler, Björn Scheffler, Ramazan Jabbarli, Daniela Pierscianek, Ulrich Sure, Teresa Schmidt, Christoph Oster, Peter Hau, Martin Glas, Wolfgang Lübcke, Martin Stuschke, Nika Guberina	2021	5
11	Comparison of early tumour-associated versus late deaths in patients with central or >7 cm T4 N0/1 M0 non-small-cell lung-cancer undergoing trimodal treatment: Only few risks left to improve European Journal of Cancer ·Nika Guberina, Christoph Pöttgen, Martin Schüler, Maja Guberina, Georgios Stamatis, Till Plönes, Bettina Krebs, Martin Metzenmacher, Dirk Theegarten, Thomas Gauler, Karl‐Heinz Jöckel, Kaid Darwiche, Clemens Aigner, Martin Stuschke, Wilfried Eberhardt	2020	4
12	A Single-Institution Analysis of the Surgical Management of Pulmonary Large Cell Neuroendocrine Carcinomas The Annals of Thoracic Surgery ·Christian Roesel, Sarah Terjung, Gerhard Weinreich, Thomas Gauler, Dirk Theegarten, Georgios Stamatis, Stefan Welter	2016	28
13	Systemic therapy in metastatic renal cell carcinoma World Journal of Urology ·Jens Bedke, Thomas Gauler, Viktor Grünwald, Axel Hegele, Edwin Herrmann, Stefan Hinz, Jan Janßen, Stephan Schmitz, Martin Schostak, Hans Tesch, Stefan Zastrow, Kurt Miller	2016	149
14	Thoracic Staging in Lung Cancer: Prospective Comparison of ¹⁸F-FDG PET/MR Imaging and ¹⁸F-FDG PET/CT Journal of Nuclear Medicine ·Philipp Heusch, Christian Buchbender, Jens Köhler, Felix Nensa, Thomas Gauler, Benedikt Gomez, Henning Reis, Georgios Stamatis, Hilmar Kühl, Verena Hartung, Till A. Heusner	2014	88
15	P-ERK, P-AKT and p53 as Tissue Biomarkers in Erlotinib-Treated Patients with Advanced Pancreatic Cancer: a Translational Subgroup Analysis From Aio-PK0104 Annals of Oncology ·Stefan Boeck, Jens T. Siveke, Steffen Ormanns, Ruediger P. Laubender, Andreas Jung, Michael Haas, Ursula Vehling‐Kaiser, Cornelia Winkelmann, Ludwig Fischer von Weikersthal, Michael Clemens, Thomas Gauler, Angela Märten, Stefan Klein, G. Kojouharoff, Michael Geißler, Tim F. Greten, Thomas Kirchner, Volker Heinemann	2013	1
16	Phase II study of pemetrexed in combination with cisplatin and cetuximab in recurrent or metastatic squamous cell carcinoma of the head and neck European Journal of Cancer ·Jan B. Vermorken, Lisa Licitra, Jan Stöhlmacher-Williams, Andreas Dietz, José M. López-Picazo, Oday Hamid, Anwar M. Hossain, Sanders Chang, Thomas Gauler	2013	23
17	Expression of Amphiregulin and EGFRvIII Affect Outcome of Patients with Squamous Cell Carcinoma of the Head and Neck Receiving Cetuximab–Docetaxel Treatment Clinical Cancer Research ·Ingeborg Tinhofer, Konrad Klinghammer, Wilko Weichert, Maren Knödler, Albrecht Stenzinger, Thomas Gauler, Volker Budach, Ulrich Keilholz	2011	76
18	Phase II trial of PTK787/ZK 222584 (vatalanib) administered orally once-daily or in two divided daily doses as second-line monotherapy in relapsed or progressing patients with stage IIIB/IV non-small-cell lung cancer (NSCLC) Annals of Oncology ·Thomas Gauler, Benjamin Besse, Audrey Mauguen, Jean‐Baptiste Méric, V. Gounant, B. Fischer, Tobias R. Overbeck, Heiko Krissel, Dirk Laurent, Marjaana Tiainen, Frédéric Commo, Jean‐Charles Soria, Wilfried Eberhardt	2011	24
19	C1-01: Phase II open-label study to investigate PTK787/ZK 222584 (PTK/ZK) orally administered as a second-line monotherapy in patients with stage IIIB or stage IV non-small-cell lung cancer (NSCLC) Journal of Thoracic Oncology ·Thomas Gauler, Benjamin Besse, Jean‐Baptiste Méric, V. Gounant, Bernhard P. Fischer, Tobias R. Overbeck, Heiko Krissel, Dirk Laurent, Jean‐Charles Soria, Wilfried Eberhardt	2007	2
20	Abstracts British Journal of Cancer ·Ahmad Awada, Jean Klášterský, M Aze ́mar, Christian Stoll, Jana Bendel, J Ha ̈usler, S. Korfee, Gerald Antoch, Thomas Gauler, Wilfried Eberhardt, Anna Kowalczyk, Rafał Dziadziuszko, Ewa Szutowicz-Zielińska, A. Badzio, Jacek Jassem	2003	1

About Thomas Gauler

Thomas Gauler is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Microbiology, having authored 152 papers that have together received 3.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (66 papers), Head and Neck Cancer Studies (36 papers), Lung Cancer Diagnosis and Treatment (33 papers), Lung Cancer Research Studies (28 papers), Radiomics and Machine Learning in Medical Imaging (16 papers), Cancer Genomics and Diagnostics (13 papers), Renal cell carcinoma treatment (11 papers) and Cancer Immunotherapy and Biomarkers (11 papers). The work is most often cited by research in Otorhinolaryngology (462 citations), Oncology (1.6k citations), Pulmonary and Respiratory Medicine (1.7k citations), Cancer Research (481 citations) and Radiology, Nuclear Medicine and Imaging (560 citations). Thomas Gauler has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Wilfried Eberhardt, Martin Stuschke, Georgios Stamatis, Ulrich Keilholz, Christoph Pöttgen, Martin Schüler, Dirk Theegarten, Lisa Licitra, Viktor Grünwald and Andreas-Claudius Hoffmann. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Journal of Thoracic Oncology and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact